# Akmpath

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/akmpath

- Industry: Healthcare
- Headquarters: Shanghai, China
- Website: www.akmpath.com
- Latest round: Series A (Apr 14, 2021)
- Investors on record: 4

## About

Akmpath is a medical institute located in China, dedicated to advancing healthcare through innovative solutions and research in the medical field. Their focus lies in developing effective healthcare technologies to improve patient outcomes.Founded in 2014, Akmpath operates as a medical institute primarily focused on healthcare advancements. Based in Shanghai, China, the company has successfully completed three deals since its inception, with its most recent deal occurring on April 14, 2021. Information about the founder is currently unavailable.Akmpath's primary offering includes advanced healthcare technologies aimed at enhancing patient care and treatment efficacy. The company focuses on developing innovative medical solutions that cater to various healthcare needs, emphasizing research and implementation of cutting-edge medical practices.The company generates revenue primarily through partnerships and direct engagements, focusing on advanced healthcare product offerings and services tailored to client needs. Revenue streams include contractual agreements with healthcare institutions, ensuring consistent support and resources for their innovative solutions.In April 2021, Akmpath raised Series A+ funding from Insight Capital and Zero2IPO Ventures, although financial terms were not disclosed. The company plans to utilize these funds to develop new healthcare products and expand into additional markets in Asia by the end of 2023, aiming to enhance their service offerings and reach a broader patient demographic.

## Funding rounds

- Series A, Apr 14, 2021 — Zero2IPO Ventures, Insight Capital
- Series A, Aug 13, 2018 — Fortune Capital, Insight Capital
- Angel, Mar 11, 2016 — Lotus Lake Capital

## Investors

- Lotus Lake Capital (https://capitalatlas.ai/funds/lotus-lake-capital) — Angel
- Fortune Capital — Series A
- Insight Capital — Series A
- Zero2IPO Ventures (https://capitalatlas.ai/funds/zero2ipo-ventures) — Series A